Production of pigs transgenic for human decay accelerating factor.
Langford
G A
GA
Department of Surgery, Cambridge University, England.
Yannoutsos
N
N
Cozzi
E
E
Lancaster
R
R
Elsome
K
K
Chen
P
P
Richards
A
A
White
D J
DJ
D000818:Animals; D030801:Animals, Genetically Modified; D015703:Antigens, CD / Q000096:biosynthesis* / Q000235:genetics; D018958:CD55 Antigens; D003169:Complement Inactivator Proteins / Q000096:biosynthesis*; D004247:DNA / Q000235:genetics / Q000302:isolation & purification; D005260:Female; D006801:Humans; D008099:Liver / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D008297:Male; D008562:Membrane Glycoproteins / Q000096:biosynthesis* / Q000235:genetics; D009206:Myocardium / Q000378:metabolism; D009928:Organ Specificity; D012333:RNA, Messenger / Q000032:analysis / Q000096:biosynthesis; D013154:Spleen / Q000378:metabolism; D013552:Swine
D015703:Antigens, CD; D018958:CD55 Antigens; D003169:Complement Inactivator Proteins; D008562:Membrane Glycoproteins; D012333:RNA, Messenger; D004247:DNA